Abstract
Thirty patients with epidermoid carcinoma of the anus, ranging in age from 40 to 89 years, were treated with combined chemotherapy (CT) and radiation therapy (RT) in lieu of abdominoperineal resection. Two courses of 5-FU (1000 mg/m2/day×four days) by continuous infusion and mitomycin-C (10–15 mg/m2 IV bolus on day 1 of each course) were given 3 to 4 weeks apart simultaneously, with whole pelvis RT to 4140 to 4500 cGy. Twenty-one of 28 patients had T3-T4 primaries and ten had positive nodes (N1). Two of the 30 patients were treated for local recurrence following surgical excision and one was treated immediately after local excision. Twenty-six of the 30 patients attained biopsy-confirmed complete remission. Four of the 30 patients demonstrated residual disease at completion of therapy but all subsequently achieved complete remission with additional nonsurgical treatment. One patient, initially treated for local recurrence following excision failed locally at four years and was salvaged with chemotherapy followed by abdominoperineal resection. No patient has experienced distant failure. Twenty-seven of 30 patients were alive and disease free after 9 to 76 months of follow-up and three died, disease-free, of unrelated causes. Acute toxicities were mild and did not necessitate interruption of treatment. A brisk perineal reaction and diarrhea were noted in all patients. Late complications were unusual. All patients were treated in a community-based, private practice setting. The authors conclude that combined CT-RT, as employed herein, represents a first-line curative treatment for the majority of patients with epidermoid anal carcinoma. For patients who demonstrate residual disease following this therapy, salvage regimens such as 5-FU infusion and cisplatin, or sequential MTX-5-FU-Leucovorin with additional synchronous RT should be employed before resorting to radical surgery.
Similar content being viewed by others
References
Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354–6.
Flam MS, John M, Lovalvo LJ, et al. Definitive nonsurgical therapy for epithelial malignancies of the anal canal: a report of 12 cases. Cancer 1983;51:1378–87.
Cummings BJ. The place of radiation therapy in the treatment of carcinoma of the anal canal. Cancer Treat Rev 1982;9:125–47.
Cummings B, Keane T, Thomas G, Harwood A, Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 1984;54:2062–8.
Leichman L, Nigro N, Vaitkevicius VK, et al. Cancer of the anal canal: model for preoperative adjuvant combined modality therapy. Am J Med 1985;78:211–5.
Hagbin M, Sischy B, Hinson J. A long term followup of definitive conservative therapy for anal canal carcinoma (abstr). Proc Am Soc Clin Oncol 1985;4:81.
Sischy B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 1985;11:1587–93.
Michaelson RA, Magill GB, Quan SH, Leaming RH, Nikrui M, Stearns MW. Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma. Cancer 1983;51:390–5.
Meeker WR Jr, Sickle-Santanello BJ, Philpott G, et al. Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal. Cancer 1986;57:525–9.
Pipard G, Peytremann R, Marti MC. Conservative multidisciplinary treatment of locally advanced epidermoid and cloacogenic cancer of the anal canal (abstr). Proc Am Soc Clin Oncol 1986;5:269.
John MJ, Flam MS, Lovalvo L, et al. Feasibility of nonsurgical definitive management of anal canal carcinoma. Int J Radiat Oncol Biol Phys 1986;13:299–303.
Flam MS, John M, Mowry P, et al. Definitive treatment of anal carcinoma with chemotherapy and radiation (abstr). Proc Am Soc Clin Oncol 1986;5:264.
Harmer MH, ed. TMN classification of malignant tumors. 3rd ed. Geneva: Untion International Contre le Cancer, 1978:77–81.
Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum 1981;24:73–5.
Ajlouni M, Mahrt D, Milad MP. Review of recent experience in the treatment of carcinoma of the anal canal. Am J Clin Oncol 1984;7:687–91.
Cortese AF. Surgical approach for treatment of epidermoid anal carcinoma. Cancer 1975;36:1869–75.
Stearns MW Jr, Urmacher C, Sternberg SS, Woodruff J, Attiyeh F. Cancer of the anal canal. Curr Probl Cancer 1980;4:1–44.
Svenson EW, Montague ED. Results of treatment in transitional cloacogenic carcinoma. Cancer 1980;46:828–30.
Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG. Epidermoid cancer of the anorectum. Cancer 1984;53:1285–93.
Salem PA, Habboubi N, Anaissie E, et al. Effectiveness of cisplatin in the treatment of anal squamous cell carcinoma. Cancer Treat Rep 1985;69:891–3.
Fisher WB, Herbst KD, Sims JE, Critchfield CF. Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin andcis-dichlorodiammineplatinum (II). Cancer Treat Rep 1978;62:91–7.
Khater R, Flenay M, Bourry J, Milano G, Namer M. Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: a report of 2 cases. Cancer Treat Rep 1986;70:1345–6.
Gewirtz AM, Cadman E. Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer 1981;47:2552–5.
Author information
Authors and Affiliations
About this article
Cite this article
Flam, M.S., John, M.J., Mowry, P.A. et al. Definitive combined modality therapy of carcinoma of the anus. Dis Colon Rectum 30, 495–502 (1987). https://doi.org/10.1007/BF02554777
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02554777